Fecal occult blood test use by Kansas Medicare beneficiaries

被引:15
作者
Engelman, KK
Ellerbeck, EF
Ahluwalia, JS
Nazir, N
Velasco, A
机构
[1] Univ Kansas, Med Ctr, Dept Prevent Med, Kansas City, KS 66160 USA
[2] Univ Kansas, Sch Med, Dept Internal Med, Kansas City, KS 66160 USA
[3] Univ Kansas, Kansas Canc Inst, Kansas City, KS 66160 USA
关键词
colorectal neoplasms; Medicare; occult;
D O I
10.1006/pmed.2001.0936
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose. The aim of this study was to examine utilization of and trends in fecal occult blood testing (FOBT) among beneficiaries since Medicare began FOBT coverage on January 1, 1998. Methods. We identified Kansas Medicare beneficiaries ages 65-79. Using Medicare claims, we determined which beneficiaries received FOBT during 1998-1999. We examined demographic variables associated with FOBT and rate changes over time. We linked beneficiaries to primary care practices (PCPs) and examined FOBT variations among 483 PCPs. Results. FOBT use remained unchanged during the study period. Of the 215,322 beneficiaries, 11% received at least one FOBT in 1998 and 11% in 1999; 18% had at least one test during the 2-year period, but only 4% had a test during both years. Caucasians and females had the highest FOBT rates. Although FOBT rates among PCPs ranged from 0 to 71%, only 19% of the practice rates exceeded 10%. Conclusions. Few beneficiaries obtain annual FOBT and little change in rates has occurred since Medicare reimbursement began. Although FOBT rates vary widely between PCPs, most either do not provide FOBT or do not bill Medicare for FOBT. The FOBT claims rate is much lower than reported in patient surveys and may indicate that Medicare should reexamine its reimbursement policy. (C) 2001 American Health Foundation and Elsevier Science.
引用
收藏
页码:622 / 626
页数:5
相关论文
共 13 条
[1]  
*AM CANC SOC, 2000, CANC PREV EARL DET F, P39
[2]  
[Anonymous], 1996, GUID CLIN PREV SERV
[3]   American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997 [J].
Byers, T ;
Levin, B ;
Rothenberger, D ;
Dodd, GD ;
Smith, RA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1997, 47 (03) :154-&
[4]   MEASURING THE USE OF MAMMOGRAPHY - 2 METHODS COMPARED [J].
DEGNAN, D ;
HARRIS, R ;
RANNEY, J ;
QUADE, D ;
EARP, JA ;
GONZALEZ, J .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1992, 82 (10) :1386-1388
[5]  
Erban S, 2001, Eff Clin Pract, V4, P10
[6]   Barriers to office-based screening sigmoidoscopy: Does reimbursement cover costs? [J].
Lewis, JD ;
Asch, DA .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (06) :525-530
[7]   Prescribe for health - Improving cancer screening in physician practices sewing low-income and minority populations [J].
Manfredi, C ;
Czaja, R ;
Freels, S ;
Trubitt, M ;
Warnecke, R ;
Lacey, L .
ARCHIVES OF FAMILY MEDICINE, 1998, 7 (04) :329-337
[8]  
Ruffin M T, 2000, J Am Board Fam Pract, V13, P1
[9]  
*SAS I, 1998, SAS STAT US GUID VER, V2
[10]  
SAS Institute, 1998, SAS STAT US GUID VER, V1